Lawaetz O, Halkier E
Scand J Thorac Cardiovasc Surg. 1980;14(1):113-7. doi: 10.3109/14017438009109865.
In order to present the possible influence of postoperative empyema on the survival rate of patients with bronchogenic carcinoma, who had been treated by pneumonectomy, a retrospective investigation was made upon 207 patients over a 10-year period. In patients with and without a complicating postoperative empyema, a cumulative survival rate of 0.04 and 0.26, respectively, was found. The difference was not significant. However, other retrospective investigations on the influence of postoperative empyema on long-term survival after surgical treatment for bronchogenic carcinoma have shown results that might stimulate prospective studies on the subject. Furthermore, this investigation showed that the probability of long-term survival was highest in patients under 60 years of age, when the bronchogenic carcinoma is a planocellular carcinoma located in the left lung without postoperative empyema. Among pneumonectomized lung cancer patients, the mortality was above expectancy, even 8-10 years after operation compared with the estimated survival rate in the average population.
为了呈现术后脓胸对接受肺切除术治疗的支气管癌患者生存率的可能影响,我们对207例患者进行了为期10年的回顾性调查。在有和没有术后脓胸并发症的患者中,累积生存率分别为0.04和0.26。差异不显著。然而,其他关于术后脓胸对支气管癌手术治疗后长期生存影响的回顾性研究显示的结果可能会促使对该主题进行前瞻性研究。此外,这项调查表明,在60岁以下的患者中,当支气管癌为位于左肺的鳞状细胞癌且无术后脓胸时,长期生存的概率最高。在接受肺切除术的肺癌患者中,与普通人群的预期生存率相比,即使在术后8至10年,死亡率仍高于预期。